Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression

Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression

Abstract Background In an 8-week, randomized, placebo-controlled, double-blind study, an extended-release formulation of quetiapine, quetiapine XR, demonstrated efficacy and safety in Japanese patients with bipolar depression. Bipolar disorder is a chronic disease requiring continuous treatment. Met...

Full description

Bibliographic Details
Main Authors: Shigenobu Kanba, Mitsukuni Murasaki, Tsukasa Koyama, Masahiro Takeuchi, Yuriko Shimizu, Eri Arita, Kentaro Kuroishi, Shinya Kamei
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Psychiatry
Subjects:
Quetiapine XR
Bipolar disorder
Depression
Online Access:http://link.springer.com/article/10.1186/s12888-019-2181-9

Internet

http://link.springer.com/article/10.1186/s12888-019-2181-9

Similar Items